Suppr超能文献

运用安德森卫生服务利用行为模型评估与患者-医疗服务提供者关于肺癌筛查讨论相关的因素。

Assessing Factors Associated With Patient-Provider Discussions About Lung Cancer Screening Using Andersen's Behavioral Model of Health Services Utilization.

作者信息

Cai Owen Y, Fernandez Jessica R, Aldrich Melinda C, Richmond Jennifer

机构信息

Department of Medicine, Health, and Society, Vanderbilt University, Nashville, TN.

Health Sciences Department, NORC at the University of Chicago, Bethesda, MD.

出版信息

Clin Lung Cancer. 2025 Jun 12. doi: 10.1016/j.cllc.2025.06.006.

Abstract

BACKGROUND

Patient-provider shared decision-making discussions are an important component of lung cancer screening guidelines, but little is known about factors associated with these discussions among screening-eligible patients. We used Andersen's Behavioral Model of Health Services Utilization to examine factors associated with discussing LCS with a provider.

PATIENTS

Data came from an online survey of N = 516 U.S. adults meeting United States Preventive Services Task Force LCS eligibility criteria (ie, were 50-80 years of age and had at least a 20-pack year history of tobacco use).

METHODS

We used logistic regression to investigate whether having a LCS discussion was associated with predisposing factors (eg, chronic obstructive pulmonary disease [COPD] diagnosis), enabling factors (eg, having a primary care provider [PCP]), and need factors (eg, smoking history).

RESULTS

About 36% participants had ever discussed LCS with a provider. Participants diagnosed with COPD (OR = 3.56, 95% CI, 1.90-6.67) and who had a first-degree relative with lung cancer (OR = 1.78, 95% CI, 1.02-3.09) had higher odds of LCS discussion than those without COPD and with no family history, respectively. Women had lower odds of LCS discussion than men (OR = 0.37, 95% CI, 0.24-0.58). Participants with an income of $30,000 to $59,999 had higher odds of LCS discussion compared to those earning < $30,000 (OR = 1.78, 95% CI, 1.06-2.98). Not having a PCP (OR = 0.39, 95% CI, 0.21-0.72) and currently smoking (OR = 0.38, 95% CI, 0.18-0.79) were associated with lower odds of LCS discussion.

CONCLUSIONS

Future interventions are needed to ensure all LCS-eligible individuals have access to provider discussions about LCS.

摘要

背景

患者与医疗服务提供者共同参与的决策讨论是肺癌筛查指南的重要组成部分,但对于符合筛查条件的患者中与这些讨论相关的因素却知之甚少。我们使用安德森的卫生服务利用行为模型来研究与与医疗服务提供者讨论肺癌筛查(LCS)相关的因素。

患者

数据来自对516名符合美国预防服务工作组肺癌筛查资格标准的美国成年人的在线调查(即年龄在50 - 80岁之间,且有至少20包年的吸烟史)。

方法

我们使用逻辑回归来研究进行肺癌筛查讨论是否与易患因素(如慢性阻塞性肺疾病[COPD]诊断)、促成因素(如有初级保健提供者[PCP])和需求因素(如吸烟史)相关。

结果

约36%的参与者曾与医疗服务提供者讨论过肺癌筛查。被诊断患有慢性阻塞性肺疾病的参与者(比值比[OR]=3.56,95%置信区间[CI],1.90 - 6.67)和有肺癌一级亲属的参与者(OR = 1.78,95% CI,1.02 - 3.09)与未患慢性阻塞性肺疾病且无家族病史的参与者相比,进行肺癌筛查讨论的几率更高。女性进行肺癌筛查讨论的几率低于男性(OR = 0.37,95% CI,0.24 - 0.58)。收入在30,000美元至59,999美元之间的参与者与收入低于30,000美元的参与者相比,进行肺癌筛查讨论的几率更高(OR = 1.78,95% CI,1.06 - 2.98)。没有初级保健提供者(OR = 0.39,95% CI,0.21 - 0.72)和目前仍在吸烟(OR = 0.38,95% CI,0.18 - 0.79)与进行肺癌筛查讨论的几率较低相关。

结论

未来需要采取干预措施,以确保所有符合肺癌筛查条件的个体都能与医疗服务提供者讨论肺癌筛查。

相似文献

6
Sertindole for schizophrenia.
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Interventions for supporting pregnant women's decision-making about mode of birth after a caesarean.
Cochrane Database Syst Rev. 2013 Jul 30;2013(7):CD010041. doi: 10.1002/14651858.CD010041.pub2.
9
Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD).
Cochrane Database Syst Rev. 2021 Jul 20;7(7):CD013196. doi: 10.1002/14651858.CD013196.pub2.
10
Reducing Smoking Requirements for Lung Screening to Address Health Disparities in a Community Cohort.
JAMA Netw Open. 2025 Jun 2;8(6):e2517149. doi: 10.1001/jamanetworkopen.2025.17149.

本文引用的文献

1
The risk and benefit profiles of US-eligible lung cancer screening attendees vs nonattendees.
J Natl Cancer Inst. 2024 Dec 1;116(12):1896-1903. doi: 10.1093/jnci/djae148.
2
Combined Breast and Lung Cancer Screening Among Dual-Eligible Women: A Descriptive Study.
J Surg Res. 2025 Mar;307:204-211. doi: 10.1016/j.jss.2024.05.024. Epub 2024 Jun 10.
3
Patient Lung Cancer Screening Decisions and Environmental and Psychosocial Factors.
JAMA Netw Open. 2024 May 1;7(5):e2412880. doi: 10.1001/jamanetworkopen.2024.12880.
4
Patient-Provider Lung Cancer Screening Discussions: An Analysis of a National Survey.
Clin Lung Cancer. 2024 Jun;25(4):e189-e195.e2. doi: 10.1016/j.cllc.2024.02.008. Epub 2024 Mar 2.
5
Prevalence of Lung Cancer Screening in the US, 2022.
JAMA Netw Open. 2024 Mar 4;7(3):e243190. doi: 10.1001/jamanetworkopen.2024.3190.
6
Cancer statistics, 2024.
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
9
Tobacco Product Use Among Adults - United States, 2021.
MMWR Morb Mortal Wkly Rep. 2023 May 5;72(18):475-483. doi: 10.15585/mmwr.mm7218a1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验